Transplant team at Mayo Clinic
Mayo Clinic's three-site Liver Transplant Program is one of the largest in the country.
Each year, Mayo's doctors and surgeons diagnose and treat thousands of people with liver disease. Mayo Clinic's three-site Liver Transplant Program is one of the largest in the country.
Mayo Clinic also has one of the largest living-donor programs in the United States. Living-donor transplant is an option that, for many people, reduces time on the waiting list for a donor liver and improves outcomes.
Mayo Clinic's Liver Transplant Program was established in 1985. Since then, Mayo Clinic has completed more than 6,700 transplants in children and adults. In 2016, Mayo Clinic's Florida campus completed its 3,000th liver transplant, a milestone that very few centers nationwide have achieved.
Innovation and research
The lifesaving potential of bioartificial livers
Researchers are developing a bioartificial liver.
Click here for an infographic to learn more
The liver transplant teams in Arizona, Florida and Minnesota are leaders and innovators in heart-liver transplants, transplants for people with liver cancer and use of anti-rejection drugs that help ensure positive outcomes.
People with challenging health situations come to Mayo Clinic for help because our doctors and surgeons are experts in specialized liver transplant options.
The Mayo Clinic Transplant Center supports many studies for liver transplant research. For example, Mayo Clinic researchers are developing a bioartificial liver that could help patients cope as they await a donor liver.
Nationally recognized expertise
Liver transplant outcomes at Mayo Clinic compare favorably with the national average.
Sept. 24, 2016
- Feldman M, et al. Liver transplantation. In: Sleisenger & Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 10th ed. Philadelphia, Pa.: Saunders; 2016. https://www.clinicalkey.com. Accessed June 13, 2016.
- Liver transplant. American Liver Foundation. http://www.liverfoundation.org/abouttheliver/info/transplant/. Accessed June 13, 2016.
- What I need to know about liver transplantation. National Institute for Diabetes and Digestive and Kidney Diseases. http://digestive.niddk.nih.gov/ddiseases/pubs/livertransplant_ez/. Accessed June 13, 2016.
- Questions & answers for transplant candidates about MELD and PELD. United Network for Organ Sharing. http://www.unos.org/docs/MELD_PELD. Accessed May 28, 2014.
- Liver Kaplan-Meier patient survival rates for transplants performed: 1997-2004. Organ Procurement and Transplantation Network. https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/#. Accessed May 28, 2016.
- Selecting a hospital. United Network for Organ Sharing http://www.transplantliving.org/before-the-transplant/getting-on-the-list/selecting-a-hospital/. Accessed June 13, 2016.
- Dove LM, et al. Liver transplantation in adults: Patient selection and pretransplantation evaluation. http://www.uptodate.com/home. Accessed June 13, 2016.
- Bambha K, et al. Model for End-stage Liver Disease (MELD). http://www.uptodate.com/home. Accessed June 13, 2016.
- Cotler S. Living donor liver transplantation. http://www.uptodate.com/home. Accessed June 13, 2016.
- Partnering with your transplant team: The patient's guide to transplantation. United Network for Organ Sharing. https://www.unos.org/wp-content/uploads/unos/WEPNTK.pdf. Accessed March 11, 2016.
- Kim WR, et al. OPTN/SRTR 2014 annual data report: Liver. American Journal of Transplantation. 2016;16:11.
- Barbara Woodward Lips Patient Education Center. Liver transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
- Glorioso JM, et al. Pivotal preclinical trial of the spheroid reservoir bioartificial liver. Journal of Hepatology. 2015;63:388.
- Yu Y, et al. Cell therapies for liver diseases. Liver Transplantation. 2012;18:9.
- Taner T, et al. Decreased chronic cellular and antibody-mediated injury in the kidney following simultaneous liver-kidney transplantation. Kidney International. 2016;89:909.
- De Assuncao TM, et al. Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes. Laboratory Investigation. 2015;95:684.
- Croome KP, et al. The use of donation after cardiac death allografts does not increase recurrence of hepatocellular carcinoma. American Journal of Transplantation. 2015;15:2704.
- Tincani G, et al. Operative risks of domino liver transplantation for the familial amyloid polyneuropathy liver donor and recipient: A double analysis. American Journal of Transplantation. 2011;11:750.
- Kitchens WH. Domino liver transplantation: Indications, techniques, and outcomes. Transplantation Reviews. 2011;25:167.
- Scientific Registry of Transplant Recipients. http://www.srtr.org/default.aspx. Accessed April 11, 2016.
- Heimbach JK (expert opinion). Mayo Clinic, Rochester, Minn. July 19, 2016.